WNT Pathway clinical trials at UCSF

1 research study open to eligible people

The Wnt pathway is how cells send signals that control growth and repair. UCSF is running a study of a drug that targets the Wnt pathway in people with advanced or spread solid tumors. UCSF is tracking safety and how well the drug works.

Showing trials for

  • FOG-001 in Locally Advanced or Metastatic Solid Tumors

    open to eligible people ages 18 years and up

    The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial adenomatous polyposis (FAP).

    San Francisco, California and other locations

Last updated: